Save time and get answers to complex questions with AI chat
Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Dabrafenib patent expiration date novartis gsk composition matter?Guselkumab patent expiration?What is the difference between apixaban and apixaban accord?Stribild expiry date?
See the DrugPatentWatch profile for Symtuza
Yes. Symtuza is designed as a single-tablet, once-daily antiretroviral regimen (a complete treatment for HIV when used appropriately). It’s taken as one tablet rather than multiple separate drugs.
Symtuza combines four antiretroviral medicines into one tablet: - darunavir (boosted with cobicistat), - emtricitabine, - tenofovir alafenamide (TAF), - cobicistat. Because all components are in the one tablet, it functions as a single-tablet regimen.
The “single-tablet regimen” concept applies when Symtuza is used as prescribed as the full HIV regimen. Clinicians may still add other medicines in certain cases (for example, specific drug–drug interactions, resistance history, or pregnancy/renal considerations), but Symtuza itself is a one-pill combination.
Other Questions About Symtuza :